A Longitudinal Examination of Aging With a Spinal Cord Injury: Cardiovascular, Cerebrovascular and Cognitive Consequences
1 other identifier
observational
92
1 country
1
Brief Summary
The general population is aging, today 12% of the United States population is older than 65 and it is estimated that by 2020 the number of people in the United States older than 65 will outnumber children younger than 5. As the general population ages, the spinal cord injury (SCI) population is also aging and it is estimated that 14% is older than 60. Although persons with SCI are living longer, life expectancy remains below that of the general population with cardiovascular and cerebrovascular diseases accounting for more than 25% of all deaths since 1995. Similar to findings in the general population, BP dysregulation may impact cognitive function, and investigators reported poorer performance on tasks of memory and attention processing in hypotensive individuals with SCI compared to a normotensive SCI cohort. Thus, it is imperative that investigators work to minimize the impact of cognitive deficits on these aspects of life quality in persons with SCI as they age. Therefore the goals of this study are: Study 1) to compare cardiovascular, cerebrovascular and cognitive function and fMRI between older individuals with SCI (50-75 years) and older age-matched controls and Study 2) to determine 3-5 year longitudinal changes in cardiovascular, cerebrovascular and cognitive function and fMRI in relatively young individuals with SCI (28-54 years) compared to relatively young age-matched controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 27, 2016
CompletedFirst Posted
Study publicly available on registry
January 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJune 26, 2023
June 1, 2023
6 years
December 27, 2016
June 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic Blood Pressure (mmHg)
To determine change in systolic blood pressure from seated rest to seated cognitive testing in subjects with and without spinal cord injury.
Up to 3 years
Secondary Outcomes (2)
Performance on tests of memory (PASAT) and processing speed (SDMT).
Up to 3 years
Cerebral Blood Flow Velocity (cm/second) from the middle cerebral arteries
Up to 3 years
Study Arms (4)
Older SCI
Individuals that are between the ages of 50-75 years old, have a traumatic SCI, level of injury between C1-T12, non-ambulatory (wheelchair dependent), AIS grade A, B, or C, and injury occurred more than 1 year ago.
Older Able-Bodied Controls
Individuals that are between the ages of 50-75 years old and primary language is English.
Longitudinal SCI
Individuals that are between the ages of 28-54 years old and previously participated in the Impact of Age on Cardiovascular, Cerebrovascular, and Cognitive Health study in a 3-5 year span.
Longitudinal Able-Bodied Controls
Individuals that are between the ages of 28-54 years old and previously participated in the Impact of Age on Cardiovascular, Cerebrovascular, and Cognitive Health study in a 3-5 year span.
Interventions
Participants that completed the Impact of Age on Cardiovascular, Cerebrovascular, Cerebrovascular and Cognitive Health study, will be re-assessed again to compare longitudinal (3-5 years) change in blood pressure, cerebral blood flow, arterial stiffness and cognitive health.
Eligibility Criteria
Study 1) 40 older (50-75 years) individuals with SCI and 20 age-matched non-SCI controls. Study 2) 30 individuals (28-54 years) with SCI and 20 age-matched non-SCI controls. Participants will be recruited from the Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health study.
You may qualify if:
- Study 1) Between the ages of 50-75 years old
- Study 2) Between the ages of 28-54 years old
- Completed Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health study
- For Both:
- Primary language is English
- Level of injury between C1-T12;
- Non-ambulatory (wheelchair dependent);
- AIS grade A, B, or C;
- Injury occurred more than 1 year ago.
You may not qualify if:
- Acute illness or infection;
- Controlled or uncontrolled hypertension or Diabetes mellitus;
- Documented history of traumatic brain injury;
- Stroke
- Epilepsy or seizure disorders;
- Multiple sclerosis \& Parkinson's disease;
- Psychiatric disorders (post-traumatic stress disorder, schizophrenia, bipolar disorder);
- Alzheimer's disease \& dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kessler Foundation Research Center
West Orange, New Jersey, 07052, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill Wecht, EdD
James J Peters VA Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Health Scientist
Study Record Dates
First Submitted
December 27, 2016
First Posted
January 18, 2017
Study Start
December 1, 2016
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
June 26, 2023
Record last verified: 2023-06